BLV-22277-15776
4 vaccinations
1 coded response
49 check-ins
0 free-text entries
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 212 / MD
- Registered
- 2021-03-22
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Timeline
-
2021-03-22
Registered in v-safe
-
2021-03-22
Dose 1 — Pfizer-BioNTech
- 2021-03-22
- 2021-03-23
- 2021-03-24
- 2021-03-25
- 2021-03-26
- 2021-03-27
- 2021-03-28
- 2021-03-29
- 2021-04-05
- 2021-04-12
-
2021-04-19
Dose 2 — Pfizer-BioNTech
- 2021-04-19
- 2021-04-20
- 2021-04-21
- 2021-04-22
- 2021-04-23
- 2021-04-24
- 2021-04-25
- 2021-04-26
- 2021-05-03
- 2021-05-10
- 2021-05-17
- 2021-05-24
- 2021-05-31
- 2021-07-19
- 2021-10-18
-
2021-11-13
Dose 3 — Pfizer-BioNTech
- 2021-11-13
- 2021-11-14
- 2021-11-15
- 2021-11-16
- 2021-11-17
- 2021-11-18
- 2021-11-19
- 2021-11-20
- 2021-11-27
- 2021-12-05
- 2021-12-11
- 2021-12-18
- 2021-12-25
- 2022-02-12
- 2022-05-14
- 2022-11-13
-
2022-12-26
Dose 4 — Pfizer-BioNTech
- 2023-01-01
- 2023-01-02
- 2023-01-09
-
2023-01-16
Survey response — day 21, dose 4MedDRA: Nasal congestion — Feeling: Fair · Be unable to work or attend schoolMedDRA releases: 2024-11
- 2023-01-23
- 2023-01-30
- 2023-02-06
- 2023-06-26
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2021-03-22 | Pfizer-BioNTech | |
| 2 | 2021-04-19 | Pfizer-BioNTech | |
| 3 | 2021-11-13 | Pfizer-BioNTech | No |
| 4 | 2022-12-26 | Pfizer-BioNTech | No |
Free text
None.
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Nasal congestion | · | · | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release